Agilent price target lowered to $150 from $155 at JPMorgan

JPMorgan analyst Rachel Vatnsdal lowered the firm’s price target on Agilent to $150 from $155 and keeps an Overweight rating on the shares. The company reported a fiscal Q3 beat on core revenue growth and adjusted earnings, but lowered its fiscal 2023 core growth outlook due to weakness in China and customer spending caution, the analyst tells investors in a research note. The firm acknowledges the guidance cut was worse than expected, but continues to believe Agilent’s financial profile and product portfolio are attractive.